Insider: Azamian Bobak R. President/CEO and Board Chair - Tarsus Pharmaceuticals, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 53,635 | 818,106 | 871,741 |
| Value | $3,019,114.15 | $46,051,186.74 | $49,070,300.89 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 08/11/2025 | DDS | 6,000 | Indirect | COM | $50.00 | $300,000.00 | 818,106 |
| 03/24/2025 | DDS | 6,000 | Indirect | COM | $50.00 | $300,000.00 | 824,106 |
| 03/20/2025 | DDS | 8,534 | Direct | COM | $50.11 | $427,638.74 | 53,635 |
| 03/19/2025 | DDS | 8,551 | Direct | COM | $47.40 | $405,317.40 | 62,169 |
| 03/18/2025 | DDS | 7,131 | Direct | COM | $46.29 | $330,093.99 | 70,720 |
| 03/18/2024 | DDS | 10,415 | Direct | COM | $30.60 | $318,699.00 | 26,456 |
| 12/27/2023 | DDS | 8,000 | Indirect | COM | $20.22 | $161,760.00 | 830,106 |
| 12/20/2023 | DDS | 9,443 | Indirect | COM | $19.96 | $188,482.28 | 868,663 |
| 12/20/2023 | DDS | 30,557 | Indirect | COM | $20.36 | $622,140.52 | 838,106 |
| 11/15/2023 | DDS | 2,896 | Indirect | COM | $18.01 | $52,156.96 | 883,210 |
| 11/15/2023 | DDS | 200 | Indirect | COM | $19.28 | $3,856.00 | 878,106 |
| 11/15/2023 | DDS | 4,904 | Indirect | COM | $18.54 | $90,920.16 | 878,306 |
| 10/18/2023 | DDS | 8,000 | Indirect | COM | $13.24 | $105,920.00 | 886,106 |
| 09/20/2023 | DDS | 8,000 | Indirect | COM | $17.21 | $137,680.00 | 894,106 |
| 08/23/2023 | DDS | 8,000 | Indirect | COM | $17.23 | $137,840.00 | 902,106 |
| 07/19/2023 | DDS | 4,174 | Indirect | COM | $19.28 | $80,474.72 | 1,009,832 |
| 07/19/2023 | DDS | 99,726 | Indirect | COM | $20.04 | $1,998,509.04 | 910,106 |
| 07/12/2023 | DDS | 9,000 | Indirect | COM | $17.35 | $156,150.00 | 1,014,006 |
| 06/21/2023 | DDS | 8,000 | Indirect | COM | $18.63 | $149,040.00 | 1,023,006 |
| 06/14/2023 | DDS | 9,000 | Indirect | COM | $18.58 | $167,220.00 | 1,031,006 |
| 06/08/2023 | DDS | 3,100 | Indirect | COM | $20.01 | $62,031.00 | 1,040,006 |
| 05/17/2023 | DDS | 8,000 | Indirect | COM | $15.90 | $127,200.00 | 1,043,106 |
| 05/10/2023 | DDS | 9,000 | Indirect | COM | $16.80 | $151,200.00 | 1,051,106 |
| 04/21/2023 | DDS | 2,311 | Indirect | COM | $15.03 | $34,734.33 | 1,070,225 |
| 04/19/2023 | DDS | 8,000 | Indirect | COM | $13.60 | $108,800.00 | 1,072,536 |
| 1 2 3 Next Last You are at page 1 of 3 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research